{"ticker": {"uuid": "c2bbda9e-5966-4277-af57-1f23639054be", "symbol": "BIOPOR", "name": "BioPorto A/S", "exchange": "CPH", "country": "DK", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "BioPorto initiates U.S. Adult Validation Study following U.S. Food and Drug Administration (FDA) feedback", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2026-06-09T10:33:04+00:00", "published_display": "09 Jun 2026 10:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioPorto A/S 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:THOXF) 2026-05-27", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQaXc0cEs5Zm02d29paFFWWWd3dnE2RzJYRWhhOGZGT0ZSVkQ2Mk5SaVlpRVJ6d2JIZHJkMjM2N0c5S0w4SzZLa3IyVldhYXgwYzVmOUtWMWdMaE9xRjlWb2pIVl9ZblpyaTg2TFdua2ctbkxFSEtkQTh1SkVQS0x3SDdpWHJ3VHJEbUNtbTZWSVJZdUt1N2hBR09xcTA?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioPorto announces Interim Result for the First Quarter of 2026", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioPorto A/S", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPSG5pX2k3eEdHRXpGNGRRZkI5ck8xaW5MSV9tZFRQeUR4VjRoRVYyNGVVQVZyTDEtUmExUzBLZUNpdWhEMUtudlBVei10XzNpVkpvYlR6dTBWaHRoY1RoNVk1NFlwWWpTU1FlLUNQUzJzVTJQVnU3Szc5bUVFTjRod2xLdFZiTENQSHJRTTh3?oc=5", "source_name": "Via Ritzau", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "BioPorto initiates U.S. Adult Validation Study following U.S. Food and Drug Administration (FDA) feedback", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2026-06-09T10:33:04+00:00", "published_display": "09 Jun 2026 10:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioPorto A/S 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:THOXF) 2026-05-27", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQaXc0cEs5Zm02d29paFFWWWd3dnE2RzJYRWhhOGZGT0ZSVkQ2Mk5SaVlpRVJ6d2JIZHJkMjM2N0c5S0w4SzZLa3IyVldhYXgwYzVmOUtWMWdMaE9xRjlWb2pIVl9ZblpyaTg2TFdua2ctbkxFSEtkQTh1SkVQS0x3SDdpWHJ3VHJEbUNtbTZWSVJZdUt1N2hBR09xcTA?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioPorto announces Interim Result for the First Quarter of 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxOTmQ3VGRkZkpQVXh3UGlsY0tLcE1NSVlCdW9Kak92c3M4NjdvVjRobk0zWnRfNmZVSkNXUDlpc1ZrUHZSak9qdEJDZElwWDNfUllDUGloWEVYRmxVQlNtVHhyaV9mZVoybTZMSFhKektiVHc4WU5Md0ZsdnpxQVR2NzhaNGxZeE1RVkkzSU1QLXpkVkVNVHpnS09WRmlIenNMWGFhZGZjNmUyT2FuTnJWSlVycjVvRWttR3NHSFMxYWptUFlEa0kwNVBwU05BekdCSnFB0gHYAUFVX3lxTFBiSWh6VlVtRHlwSDQzcTFTZVVSWEp2dllfZnRxWUZwYlNIUlJRQ19uMGdnT0E4bEVPX3gwT0t3NVQwel9KWWlOdm1XeWZLRTRtNEVvaXoxREdRcWZuNTR1LUE2RE93cUFFNHpERGZWSWFsOGtKdm50RU9MbE90V25IVExjNk5ySnJSVUVtbzdSeS1VVFZTRE9fMGRXcjg3eVFUUlNORDBJa2U0UWNYWURfcTdfZ3pQV2VaU2xjcmRGQ2luR1Jtc3h1NFNHb1ZpWklnOUxVb0JndA?oc=5", "source_name": "The Manila Times", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioPorto A/S", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPSG5pX2k3eEdHRXpGNGRRZkI5ck8xaW5MSV9tZFRQeUR4VjRoRVYyNGVVQVZyTDEtUmExUzBLZUNpdWhEMUtudlBVei10XzNpVkpvYlR6dTBWaHRoY1RoNVk1NFlwWWpTU1FlLUNQUzJzVTJQVnU3Szc5bUVFTjRod2xLdFZiTENQSHJRTTh3?oc=5", "source_name": "Via Ritzau", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 77, "total_relevant": 4, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 4, "score": 50, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 65, "events": [{"event": "earnings", "label": "Earnings", "weight": 1.45, "count": 2}, {"event": "general", "label": "Market update", "weight": 1.1, "count": 2}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 1.17, "latest_week": "2026-06-19", "one_week_move": -0.8, "four_week_move": -6.0, "twelve_week_move": 34.8, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.094636, "market_dynamics_buy_signal": false, "relative_strength": -0.647176, "fair_value_gap": -23.3, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.9775, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.8% over one week, -6.0% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 43, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "The Manila Times", "count": 2}, {"label": "Seeking Alpha", "count": 1}, {"label": "Via Ritzau", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 2}, {"label": "Earnings", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "65/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-0.8% over one week, -6.0% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "BioPorto initiates U.S. Adult Validation Study following U.S. Food and Drug Administration (FDA) feedback"}], "updated_at": "2026-06-24T01:54:19.211720+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}